Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	83.69	13.57	7.39
Graham Fair Price	-72.86	1.40	5.17
PEG	2566.27	-0.50	0.02
Price/Book	7.61	0.97	0.90
Price/Cash Flow	7.71	13.25	12.30
Prices/Earnings	1267.52	45.82	3.35
Price/Sales	7.61	1.32	1.22
Price/FCF	7.71	13.25	12.30
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	21.82	0.29	0.24
Operating Margin	-81.21	0.03	0.16
ROA	-92.36	< 0.005	0.02
ROE	0.07	< 0.005	-92.13
ROIC	0.05	< 0.005	-89.46
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.01	-0.02	-25.90
Dividends QOQ	0.10	-0.02	-77.77
EBIT QOQ	0.51	-0.82	60.19
EPS QOQ	1.80	-0.92	-48.71
FCF QOQ	0.86	-0.03	-96.47
Revenue QOQ	0.10	-0.03	-69.70
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	56.86	55.87	-1.74
Days Sales Outstanding (DSO)	53.32	45.30	-15.05
Inventory Turnover	1.58	1.61	1.77
Debt/Capitalization	0.45	0.46	2.32
Quick Ratio	0.73	0.69	-5.79
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	4.21	4.07	-3.24
Cash	1.79	1.92	7.00
Capex	-0.20	-0.25	-22.52
Free Cash Flow	0.31	0.30	-3.34
Revenue	3.10	3.00	-3.25
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.21	1.21	0.15
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.32	3.90	68.16
Naive Interpretation	Member

06 - Financial Health · Weak

Rating